metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology P- 63 UTILITY OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT IN TREATING COMPL...
Información de la revista
Vol. 29. Núm. S1.
Abstracts of the 2023 Annual Meeting of the ALEH
(febrero 2024)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 29. Núm. S1.
Abstracts of the 2023 Annual Meeting of the ALEH
(febrero 2024)
Acceso a texto completo
P- 63 UTILITY OF TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT IN TREATING COMPLICATIONS OF PORTAL HYPERTENSION: EXPERIENCE IN UNIT OF LIVER TRANSPLANTATION IN URUGUAY
Visitas
178
Romina Rey1, Martin Elizondo1, Juan Carlos Bandi2, Marcelo Vicente Valverde1, Solange Gerona1
1 Bi- Intuitional Unit of Liver Transplantation, Hospital Militar, Montevideo, Uruguay
2 Hepatology and Liver Transplantation Unit, Hospital Italiano, Buenos Aires, Argentina
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Descargar PDF
Estadísticas
Figuras (1)
Suplemento especial
Este artículo forma parte de:
Vol. 29. Núm S1

Abstracts of the 2023 Annual Meeting of the ALEH

Más datos
Introduction and Objectives

Trans jugular intrahepatic portosystemic shunt (TIPS) is the major therapeutic alternative for treating portal hypertension-related complications (PHT) that do not respond to medical treatment. It is commonly used as a bridge therapy to liver transplantation (LT). TIPS improves quality of life, overall survival, and LT-free survival while reducing the incidence of decompensation. Adequate patient selection is crucial for rightful indication. This study aimed to present the utility of TIPS on the complications of refractory PHT that don´t respond to standard of care medical treatment.

Materials and Methods

From July 2017 to December 2022, all consecutive patients with PHT admitted to receiving TIPS creation were retrospectively analyzed. The objective was to decrease the portal pressure gradient below 12 mmHg or >50% of its baseline. Follow-up was performed using Doppler ultrasound to monitor permeability and function.

Results

264 patients were evaluated for LT, of whom 15 had complications of refractory PHT that did not respond to medical treatment (Table1). Nine were females and six males. Mean age of 47 years old. Eight (53%) had refractory ascites, and seven (47%) had recurrent variceal bleeding. The median follow-up period was 38 (1-66) months. Success was assessed based on hemodynamic, clinical, and imaging parameters. All patients had favorable outcomes, with transient hepatic encephalopathy observed in 3 cases and hemolytic anemia in one case. Global dysfunction occurred in 20% of patients at one year but was corrected through stent angioplasty. Four patients underwent transplantation, and eight were removed from list due to clinical improvement. Two patients died, and one is currently on the waiting list. Overall survival rates were 93% at one year and 87% at three years.

Conclusions

TIPS is a highly useful therapeutic tool which is applied in our center. Proper patient selection allows for similar overall and transplant- free survival rates as reported internationally.

El Texto completo está disponible en PDF
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos